Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Queensland, St. Lucia, Australia.
Cytotherapy. 2011 Mar;13(3):366-77. doi: 10.3109/14653249.2010.518610. Epub 2010 Sep 22.
Despite the availability of modern antibiotics/antimycotics and cytokine support, neutropenic infection accounts for the majority of chemotherapy-associated deaths. While transfusion support with donor neutrophils is possible, cost and complicated logistics make such an option unrealistic on a routine basis. A manufactured neutrophil product could enable routine prophylactic administration of neutrophils, preventing the onset of neutropenia and substantially reducing the risk of infection. We examined the use of pre-culture strategies and various cytokine/modulator combinations to improve neutrophil expansion from umbilical cord blood (UCB) hematopoietic stem and progenitor cells (HPC).
Enriched UCB HPC were cultured using either two-phase pre-culture strategies or a single phase using various cytokine/modulator combinations. Outcome was assessed with respect to numerical expansion, cell morphology, granulation and respiratory burst activity.
Pre-culture in the absence of strong differentiation signals (e.g. granulocyte colony-stimulating factor; G-CSF) failed to provide any improvement to final neutrophil yields. Similarly, removal of differentiating cells during pre-culture failed to improve neutrophil yields to an appreciable extent. Of the cytokine/modulator combinations, the addition of granulocyte-macrophage (GM)-colony-stimulating factor (CSF) alone gave the greatest increase. In order to avoid production of monocytes, it was necessary to remove GM-CSF on day 5. Using this strategy, neutrophil expansion improved 2.7-fold.
Although all cytokines and culture strategies employed have been reported previously to enhance HPC expansion, we found that the addition of GM-CSF alone was sufficient to improve total cell yields maximally. The need to remove GM-CSF on day 5 to avoid monocyte differentiation highlights the context and time-dependent complexity of exogenous signaling in hematopoietic cell differentiation and growth.
尽管有现代抗生素/抗真菌药物和细胞因子支持,中性粒细胞减少性感染仍是化疗相关死亡的主要原因。虽然可以用供体中性粒细胞进行输血支持,但成本和复杂的物流使得这种选择在常规基础上不切实际。制造的中性粒细胞产品可以使常规预防性给予中性粒细胞成为可能,防止中性粒细胞减少的发生,并大大降低感染的风险。我们研究了使用预培养策略和各种细胞因子/调节剂组合来改善脐带血(UCB)造血干细胞和祖细胞(HPC)中中性粒细胞的扩增。
使用两种相预培养策略或一种使用各种细胞因子/调节剂组合的单相策略培养富集的 UCB HPC。根据数值扩增、细胞形态、颗粒形成和呼吸爆发活性来评估结果。
在没有强分化信号(例如粒细胞集落刺激因子;G-CSF)的预培养中,最终中性粒细胞产量没有任何改善。同样,在预培养过程中去除分化细胞也不能显著提高中性粒细胞产量。在细胞因子/调节剂组合中,单独添加粒细胞-巨噬细胞(GM)-集落刺激因子(CSF)可获得最大增加。为了避免产生单核细胞,有必要在第 5 天去除 GM-CSF。使用这种策略,中性粒细胞扩增提高了 2.7 倍。
尽管以前报道过所有细胞因子和培养策略都可以增强 HPC 的扩增,但我们发现单独添加 GM-CSF 足以最大限度地提高总细胞产量。需要在第 5 天去除 GM-CSF 以避免单核细胞分化,这突出了外源性信号在造血细胞分化和生长中的上下文和时间依赖性复杂性。